Delivery Order SPE2DB22D1202-SPE2DB23FHPU9
Award Date 5/17/23
Potential Completion Date 5/18/23
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00. The contract covers the delivery of 4,563,617,369 units of Vyvanse 30 mg capsules, a specialty medication, to support military and veterans' healthcare programs. The award has a ceiling value of $1,755.19 and an ultimate completion date of February 12, 2024. The...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,691.11 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, the corporate office division of parent company Cencora, Inc. The contract is for the supply of 4,564,287,260 units of the prescription medication Vyvanse 50 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen, valued up to $999,999,999.00 through December 2025, under which the...
- This federal contract award, valued at $1,377.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,172,639 units of Vyvanse 60 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $7,758 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the supply of 4,565,389,732 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,337.89 firm fixed-price delivery order is for the supply of 4,563,447,787 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,933,271 units of the prescription drug Vyvanse 30 mg capsules. The $1,374.00 firm-fixed-price contract has a completion date of June 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,562,306,642 units of Vyvanse 70 mg capsules. The firm-fixed-price delivery order, valued at $1,964.75, has an ultimate completion date of September 27, 2023. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the delivery of 4,568,434,774 units of Vyvanse 40 mg capsules. The contract has a firm fixed price of $2,350.74 and a completion date of June 4, 2025. This is a non-set-aside delivery order contract, indicating open competition. Amerisourcebergen Drug Corp is a key supplier of pharmaceutical products and medical supplies to various...